Articles

Those starting with lower A1C levels more likely to achieve A1C goal within five months….

New published research assessed the feasibility of engaging adults with diabetes in self-management behaviors between clinic visits by using cell phone text messaging to provide blood sugar measurement prompts and appointment reminders….

Active people saw their blood glucose rates jump after meals when they cut back on exercise for just three days….

Research has revealed that interrupting sitting time with short bouts of light exercise can lower glucose and insulin levels by as much as 30%.…

Patients with advanced heart failure and type 2 diabetes showed improvement after three months of consuming epicatechin-enriched cocoa.…

People with shorter arm length are at higher risk for type 2 diabetes….

Thirty-five percent of the time for 250,000 newly diagnosed diabetes patients, physicians did not follow the ADA/EASD consensus guidelines for recommended treatment.…

The high cost of diagnosing peripheral neuropathy could be greatly reduced if doctors ordered the right tests.…

The FDA Endocrinologic and Metabolic Drugs Advisory Committee voted overwhelmingly (20 to 2) in favor of approving the obesity drug Qnexa (Vivus, Inc.), a combination of phentermine and controlled-release topiramate. Qnexa could be the first prescription drug for obesity to reach the market since 1999.…

An FDA advisory committee’s endorsement of the anti-obesity drug Qnexa could re-energize the pharmaceutical industry after several years of disappointment in trying to develop anti-obesity drugs.…